Latest news
Silence Therapeutics trial cuts phlebotomies to 0.2 per patient - Stock TitanStock Titan · Mon, 10 Aug 2026 11:33:40 GMTSilence Therapeutics (SLN) halves losses and funds operations into 2028 in Q2 update - Stock TitanStock Titan · Mon, 10 Aug 2026 11:26:59 GMTSilence Therapeutics (SLN) halves net loss and boosts cash in Q2 2026 - Stock TitanStock Titan · Mon, 10 Aug 2026 11:20:49 GMTSilence Therapeutics Finishes Dosing 48 Patients in Blood Disorder Trial - Stock TitanStock Titan · Mon, 10 Aug 2026 11:15:00 GMTSilence Therapeutics to Discuss Divesiran Trial Results Aug. 10 - Stock TitanStock Titan · Sun, 09 Aug 2026 21:00:00 GMTSilexion Therapeutics (NASDAQ: SLXN) files S-1 for best-efforts unit sale - Stock TitanStock Titan · Fri, 07 Aug 2026 22:52:53 GMTFour Bills' Players Whose Stock Is Silently Soaring on Defense - Sports IllustratedSports Illustrated · Thu, 06 Aug 2026 13:28:03 GMTTreasuries, Gold and the S&P 500: The Assets Growing Fastest On-Chain Are the Most Traditional Ones - Stock TitanStock Titan · Thu, 06 Aug 2026 05:03:30 GMT